Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period
Aim: Breast cancer is the second leading cause of cancer-related deaths in women. Approximately 20-25% of breast cancers express HER2 and are associated with poor prognosis. With the use of HER2-targeted therapies, there has been an increase in treatment success for breast cancer cells overexpressin...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2025-04-01
|
| Series: | Acta Haematologica Oncologica Turcica |
| Subjects: | |
| Online Access: | https://actaoncologicaturcica.com/articles/evaluation-of-the-effect-of-radiotherapy-timing-on-toxicity-in-her2-positive-breast-cancer-receiving-trastuzumab-emtansine-during-the-adjuvant-period/doi/ahot.galenos.2024.15921 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|